100 HCA Healthcare Hospitals Earn Healthgrades Patient Safety Excellence Award
HCA Healthcare (NYSE:HCA) has achieved a significant milestone with 100 of its hospitals receiving the 2025 Patient Safety Excellence Award from Healthgrades, placing them in the top 10% of hospitals nationwide for patient safety. The recognition is based on risk-adjusted complication and mortality rates evaluated across approximately 4,500 hospitals.
Additionally, 49 HCA Healthcare hospitals were named among America's 250 Best Hospitals for 2025, representing the top 5% nationally for clinical excellence. The healthcare provider implements comprehensive safety measures through dedicated quality teams, including event reporting, serious event analysis, and advanced technologies like barcode medication administration.
HCA Healthcare's research contributions include notable studies such as the INSPIRE trials, CLUSTER trial, Swap Out trial, and ABATE Infection Trial, focusing on improving antibiotic stewardship, infection control, and patient safety. The organization's Patient Safety Organization (PSO) continues to enhance healthcare delivery through systematic improvements and fostering a culture of safety.
HCA Healthcare (NYSE:HCA) ha raggiunto un traguardo significativo con 100 dei suoi ospedali che hanno ricevuto il Premio Eccellenza nella Sicurezza dei Pazienti 2025 da Healthgrades, collocandoli nel top 10% degli ospedali a livello nazionale per la sicurezza dei pazienti. Il riconoscimento si basa su tassi di complicazioni e mortalità aggiustati per rischio, valutati su circa 4.500 ospedali.
Inoltre, 49 ospedali di HCA Healthcare sono stati nominati tra i 250 Migliori Ospedali d'America per il 2025, rappresentando il 5% migliore a livello nazionale per eccellenza clinica. Il fornitore di assistenza sanitaria implementa misure di sicurezza complete attraverso squadre di qualità dedicate, inclusi la segnalazione di eventi, l'analisi di eventi gravi e tecnologie avanzate come la somministrazione di farmaci tramite codice a barre.
Le contribuzioni alla ricerca di HCA Healthcare includono studi significativi come gli studi INSPIRE, il trial CLUSTER, il trial Swap Out e il trial ABATE Infection, focalizzandosi sul miglioramento della gestione degli antibiotici, del controllo delle infezioni e della sicurezza dei pazienti. L'Organizzazione per la Sicurezza dei Pazienti (PSO) dell'organizzazione continua a migliorare la fornitura di assistenza sanitaria attraverso miglioramenti sistematici e promuovendo una cultura della sicurezza.
HCA Healthcare (NYSE:HCA) ha alcanzado un hito significativo con 100 de sus hospitales recibiendo el Premio de Excelencia en Seguridad del Paciente 2025 de Healthgrades, colocándolos en el top 10% de hospitales a nivel nacional por seguridad del paciente. El reconocimiento se basa en tasas de complicaciones y mortalidad ajustadas por riesgo, evaluadas en aproximadamente 4,500 hospitales.
Además, 49 hospitales de HCA Healthcare fueron nombrados entre los 250 Mejores Hospitales de América para 2025, representando el 5% superior a nivel nacional por excelencia clínica. El proveedor de atención médica implementa medidas de seguridad integrales a través de equipos de calidad dedicados, incluyendo la notificación de eventos, el análisis de eventos graves y tecnologías avanzadas como la administración de medicamentos mediante código de barras.
Las contribuciones de investigación de HCA Healthcare incluyen estudios notables como los ensayos INSPIRE, el ensayo CLUSTER, el ensayo Swap Out y el ensayo ABATE Infection, centrados en mejorar la gestión de antibióticos, el control de infecciones y la seguridad del paciente. La Organización de Seguridad del Paciente (PSO) de la organización continúa mejorando la prestación de atención médica a través de mejoras sistemáticas y fomentando una cultura de seguridad.
HCA Healthcare (NYSE:HCA)는 100개의 병원이 Healthgrades로부터 2025년 환자 안전 우수상을 수상하여 전국 병원 중 환자 안전에서 상위 10%에 해당하는 중요한 이정표를 달성했습니다. 이 인정은 약 4,500개의 병원에서 평가된 위험 조정 합병증 및 사망률을 기반으로 합니다.
또한, HCA Healthcare의 49개 병원이 2025년 미국 250대 병원 중 하나로 선정되어 임상 우수성에서 전국 상위 5%를 대표합니다. 이 의료 제공자는 사건 보고, 중대한 사건 분석 및 바코드 약물 관리와 같은 고급 기술을 포함하여 전담 품질 팀을 통해 포괄적인 안전 조치를 시행합니다.
HCA Healthcare의 연구 기여에는 항생제 관리, 감염 통제 및 환자 안전 향상에 초점을 맞춘 INSPIRE 시험, CLUSTER 시험, Swap Out 시험 및 ABATE 감염 시험과 같은 주목할 만한 연구가 포함됩니다. 조직의 환자 안전 조직(PSO)은 체계적인 개선을 통해 의료 제공을 강화하고 안전 문화 조성을 지속하고 있습니다.
HCA Healthcare (NYSE:HCA) a atteint un jalon significatif avec 100 de ses hôpitaux recevant le Prix d'Excellence en Sécurité des Patients 2025 de Healthgrades, les plaçant dans le top 10% des hôpitaux à l'échelle nationale pour la sécurité des patients. La reconnaissance est basée sur des taux de complications et de mortalité ajustés au risque, évalués dans environ 4 500 hôpitaux.
De plus, 49 hôpitaux HCA Healthcare ont été nommés parmi les 250 Meilleurs Hôpitaux d'Amérique pour 2025, représentant le meilleur 5% au niveau national pour l'excellence clinique. Le fournisseur de soins de santé met en œuvre des mesures de sécurité complètes grâce à des équipes de qualité dédiées, y compris le signalement d'événements, l'analyse d'événements graves et des technologies avancées comme l'administration de médicaments par code-barres.
Les contributions de recherche d'HCA Healthcare incluent des études notables telles que les essais INSPIRE, l'essai CLUSTER, l'essai Swap Out et l'essai ABATE Infection, axées sur l'amélioration de la gestion des antibiotiques, du contrôle des infections et de la sécurité des patients. L'Organisation pour la Sécurité des Patients (PSO) de l'organisation continue d'améliorer la prestation des soins de santé grâce à des améliorations systématiques et à la promotion d'une culture de la sécurité.
HCA Healthcare (NYSE:HCA) hat einen bedeutenden Meilenstein erreicht, indem 100 seiner Krankenhäuser den 2025 Patientensicherheits-Exzellenzpreis von Healthgrades erhalten haben, wodurch sie zu den besten 10% der Krankenhäuser im ganzen Land für Patientensicherheit gehören. Die Anerkennung basiert auf risikoadjustierten Komplikations- und Sterblichkeitsraten, die in etwa 4.500 Krankenhäusern bewertet wurden.
Darüber hinaus wurden 49 Krankenhäuser von HCA Healthcare unter den 250 besten Krankenhäusern Amerikas für 2025 benannt, was die besten 5% in Bezug auf klinische Exzellenz auf nationaler Ebene repräsentiert. Der Gesundheitsdienstleister implementiert umfassende Sicherheitsmaßnahmen durch engagierte Qualitätsteams, einschließlich Ereignisberichterstattung, Analyse schwerwiegender Ereignisse und fortschrittlicher Technologien wie der Medikamentenverabreichung über Barcodes.
Die Forschungsbeiträge von HCA Healthcare umfassen bemerkenswerte Studien wie die INSPIRE-Studien, die CLUSTER-Studie, die Swap Out-Studie und die ABATE-Infektionsstudie, die sich auf die Verbesserung des Antibiotika-Managements, der Infektionskontrolle und der Patientensicherheit konzentrieren. Die Patientensicherheitsorganisation (PSO) der Organisation verbessert weiterhin die Gesundheitsversorgung durch systematische Verbesserungen und die Förderung einer Sicherheitskultur.
- None.
- None.
Named among the nation’s top hospitals for exceptional, patient-centered care
“Patient safety will always be at the forefront of our priorities,” said Dr. Michael Cuffe, executive vice president and chief clinical officer of HCA Healthcare. “I am proud of all of our hospitals and their staff, who continue to strive for clinical excellence, going above and beyond to provide high-quality, compassionate care to the patients who come through our doors.”
Recognition on this list is based solely on patient outcomes. To determine the top-performing hospitals for patient safety, Healthgrades evaluated risk-adjusted complication and mortality rates for approximately 4,500 hospitals nationwide. The annual study found that patients treated in hospitals that received the 2025 Patient Safety Excellence Award have a significantly lower chance of experiencing certain complications than patients treated at non-recipient hospitals.
Earlier this year, 49 HCA Healthcare hospitals were named on the 2025 Healthgrades America’s 250 Best Hospitals list for being within the top
Across HCA Healthcare, dedicated quality teams strive to engineer patient safety into day-to-day operations across the health system. These teams are responsible for overseeing event reporting, serious event analysis, safe tables, and technologies such as barcode medication administration, among other programs. Safety initiatives are measured partly through a Culture of Safety survey, which is designed to help drive safety agendas and ensure the voices of colleagues are valued and leveraged to deliver safe, quality care.
HCA Healthcare’s Patient Safety Organization (PSO), established more than a decade ago, is dedicated to improving patient safety and the quality of healthcare delivery by partnering with HCA Healthcare facilities to build systems, refine processes and foster a culture of safety. Intentionally focusing on protecting conversations around patient safety, the PSO holds an annual, enterprise-wide “Safe Table” campaign to encourage all colleagues to share concerns and ideas related to the delivery of safe, quality care.
The organization has a long history of prioritizing and working to continually improve patient safety and has worked with prominent public and private institutions on industry research, including:
- The INSPIRE trials, two large multi-state studies conducted at 59 HCA Healthcare hospitals that identified a better way to target appropriate antibiotics for patients hospitalized with pneumonia or urinary tract infection, enabling better antibiotic stewardship in hospitals.
-
The CLUSTER trial, a large multi-state study conducted at 82 HCA Healthcare hospitals that found an automated outbreak detection tool reduced the size of outbreaks by
64% in the trial period preceding the COVID-19 pandemic. -
The Swap Out trial, which found that a nasal antibiotic ointment used daily for intensive care unit (ICU) patients in only one-third of
U.S. hospitals at the time, is highly effective at preventing Staphylococcus aureus infections in critically ill patients, outperforming an antiseptic solution. -
The ABATE Infection Trial, which found that an infection control technique achieved a
31% reduction in bloodstream infections and nearly a40% reduction in antibiotic-resistant bacteria among non-ICU patients with central line catheters and lumbar drains. -
The REDUCE MRSA study, which found that using antimicrobial soap and ointment to decolonize all ICU patients reduced bloodstream infections by
44% and MRSA by37% .
HCA Healthcare has also helped develop evidence-based perinatal protocols through a longstanding partnership with March of Dimes, including prohibiting elective delivery prior to 39 weeks to help babies have a healthy start to life. Additionally, HCA Healthcare developed the Sepsis Prediction and Optimization of Therapy (SPOT) tool, a system to help clinicians more quickly identify patients with sepsis.
About HCA Healthcare
All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250313031074/en/
INVESTOR CONTACT:
Frank Morgan
615-344-2688
MEDIA CONTACT:
Harlow Sumerford
615-344-1851
Source: HCA Healthcare
FAQ
How many HCA Healthcare hospitals received the 2025 Healthgrades Patient Safety Excellence Award?
What percentage reduction in bloodstream infections did HCA's ABATE Infection Trial achieve?
How many HCA hospitals were named in Healthgrades America's 250 Best Hospitals list for 2025?
What was the impact of HCA Healthcare's CLUSTER trial on hospital outbreak detection?
What were the results of HCA Healthcare's REDUCE MRSA study?
